Analysis of randomized controlled proceedings information shows non-Caucasian high-risk PCI patients importantly payment from Impella-support
Related Content
October 14, 2022 — Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...
October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...
October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a caller investigation of results from the SOLOIST-WHF Phase ...
September 8, 2022 — A objective proceedings led by investigators from Brigham and Women’s Hospital has recovered that the semipermanent ...
August 17, 2022 — A survey carried retired by scientists astatine the Centro Nacional de Investigaciones Cardiovasculares (CNIC) ...
August 12, 2022 — Older adults with atrial cardiopathy (a major, often undetected cardiac origin of stroke) whitethorn beryllium astatine ...
August 8, 2022 — Two years ago, University of Alabama astatine Birmingham researchers and colleagues reported that reductive ...
July 22, 2022 — BioSig Technologies, Inc. a aesculapian exertion institution advancing electrophysiology workflow by ...
July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical institution focused connected processing and commercializing products that ...
Subscribe Now